ALPCO’s Post

Dive deeper into Crohn’s Disease (CD) management with our Biomarker Monitoring resource! Developed in collaboration with the American Gastroenterological Association (AGA), it distills the essence of AGA's new Clinical Practice Guideline. Check out our blog post here: bit.ly/4aiyYMt #AGA #AGAGuidelines #Biomarkers #CrohnsDisease #CrohnsResearch #CrohnsAwareness #CrohnsManagement #CD #CDResearch #CDAwareness #CDManagement

Enhance your Crohn’s Disease (CD) management approach today! Our latest infographic developed with the American Gastroenterological Association (AGA)’s new Clinical Practice Guideline, sheds light on biomarker monitoring strategies for comprehensive evaluation.    Download now and evaluate your practice: bit.ly/48S0OgN #AGA #AGAGuidelines #Biomarkers #CrohnsDisease #CrohnsResearch #CrohnsAwareness #CrohnsManagement #CD #CDResearch #CDAwareness #CDManagement 

Navigate scenarios with Crohn’s Disease (CD) – from symptomatic remission to postoperative care, ALPCO’s Biomarker Monitoring for the Management of CD infographic will serve as a helpful guide.    Download today for a fresh perspective on CD management: bit.ly/3UXO70M #AGA #AGAGuidelines #Biomarkers #CrohnsDisease #CrohnsResearch #CrohnsAwareness #CrohnsManagement #CD #CDResearch #CDAwareness #CDManagement

Have you checked out our Biomarker Monitoring for the Management of Crohn’s Disease infographic yet? This resource offers more than just guidance—it's a pathway to strategic CD management. Explore how biomarkers like fecal calprotectin and C-reactive protein (CRP) can inform decisions for patients in diverse scenarios, from symptomatic remission to postoperative care. Empower yourself with knowledge and elevate your approach to CD management today and in the future. Learn more here: bit.ly/4aDlTgj #AGA #AGAGuidelines #Biomarkers #CrohnsDisease #CrohnsResearch #CrohnsAwareness #CrohnsManagement #CD #CDResearch #CDAwareness #CDManagement

The American Gastroenterological Association (AGA) recently endorsed the use of biomarker monitoring in the management of Crohn’s Disease. Learn about the suggested biomarker monitoring schedules in our infographic: bit.ly/434D7AJ #AGA #AGAGuidelines #Biomarkers #CrohnsDisease #CrohnsResearch #CrohnsAwareness #CrohnsManagement #CD #CDResearch #CDAwareness #CDManagement

Are you attending the European Congress on Obesity in May? Don't miss the chance to meet #Perspectum's Pharma Solutions team! Book and appointment with one of our team members to learn about our leadership in using imaging to identify and monitor multi-organ disease in clincal trials. Let us help you revolutionize your approach to clinical trials in obesity-related liver diseases. See you there! #ECO24 #clinicaltrials

Our goal is to make therapies accessible for the >90% of people with a #raredisease who lack them. Join us on October 1st for the 1st Annual Respiratory Rare Disease Accelerator Day at The Francis Crick Institute. 👉 https://lnkd.in/ezN7RDuz Globally, more than 300 million people are living with #rarediseases, of which one in 20 are related to #respiratory conditions. While rare on their own, collectively they represent significant social and economic costs. Given more than 90% of rare diseases lack an FDA-approved treatment, rare respiratory diseases represent a phenomenal growth opportunity. With our new LifeArc Centre for Rare Respiratory Diseases, we embody this bold ambition to improve diagnosis and care for patients living with rare respiratory disease and foster innovation for much-needed treatments and cures. Leading with three disease exemplars, we aim to de-risk translation from discovery through to clinical trials. We showcase primary ciliary dyskinesia (PCD), which affects 1:7000 births, which impairs mucociliary clearance leading to decline in lung function similar to #cysticfibrosis (CF). Unlike #CF, no approved treatments exist for PCD, despite a similar market size and unmet significant need. Together, we aim to change this.   This event will have wider applicability across rare disease and #personalisedmedicine showing how we can connect all the dots to market. With support from Weatherden, LifeArc, AXON and Pinsent Masons #Raredisease #CysticFibrosys #PCDResearch #genetherapy #respiratorymedicine #translationalmedicine #CRISPR #genomics #MolecularDiagnosis #bronchiectastis

A new illustration for The Lancet Haematology's May issue. Treating Vaso-Occlusive Events in Patients with Sickle Cell Disease. The full series of illustrations for the year so far can be found at: https://lnkd.in/eD7Ggt-j #illustration #sciencecommunication #illustrator #haematology #scienceart #thelancet #scienceillustration

Today the EMA rejects #Biogen/#Eisai application for the commercialization of Lecanemab for #Alzheimer's disease in Europe because they argue that the risks overweight the potential benefits. Right or wrong, this decision highlights the desperate need for #precisionmedicine in this field. Acknowledging the biological heterogeneity in AD is the key to unlock patient stratification and reach significant benefits with minimal risk.

Another EHA congress in Madrid! A great opportunity for the Physicians to share practices and Pharma industry to present best approaches against hematologic challenges for the optimal disease management and best patient outcome! Bringing hope through science! In a Challenging Landscape find power! #Oncopeptides #Ariti New insights in Multiple Myeloma treatment